Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 105, 96-106
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573607, 81202917)
- Science and Technology Planning Project of Guangdong Province (2015A020211036)
This publication has 37 references indexed in Scilit:
- Mitogen-activated protein kinases in innate immunityNature Reviews Immunology, 2013
- Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathwayCancer Letters, 2011
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and terminationCytokine, 2009
- Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory painJournal of Biomedical Science, 2009
- Effects of honokiol and magnolol on acute and inflammatory pain models in miceLife Sciences, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Magnolol stimulates steroidogenesis in rat adrenal cellsBritish Journal of Pharmacology, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.Journal of Clinical Investigation, 1990